Rv Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 88.50 Cr
- Paid Up Capital ₹ 61.41 Cr
- Company Age 33 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 75.67 Cr
- Satisfied Charges ₹ 115.61 Cr
- Revenue Growth 47.23%
- Profit Growth 118.45%
- Ebitda 80.59%
- Net Worth 1.58%
- Total Assets 1.55%
About Rv Lifesciences
Rv Lifesciences Limited (RLL) is a leading Public Limited Indian Non-Government Company incorporated in India on 01 October 1991 and has a history of 33 years and four months. Its registered office is in Aurangabad, Maharashtra, India.
The Corporate was formerly known as Rvhealthcare (India) Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 88.50 Cr and a paid-up capital of Rs 61.41 Cr.
The company currently has active open charges totaling ₹75.67 Cr. The company has closed loans amounting to ₹115.61 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Rv Lifesciences Limited India are Juie Pavle as COMPANY SECRETARY and Hitesh Bhandari as Cfo. Rajesh Kumar, Subrata Burman, Rajiv Sharma, and Eight other members serve as directors at the Company.
Company Details
- Location
Aurangabad, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24230MH1991PLC063442
- Company No.
063442
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
01 Oct 1991
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
What products or services does Rv Lifesciences Limited offer?
Rv Lifesciences Limited offers a wide range of products and services, including Digestive System Drugs & Medicines, Gastrointestinal Drugs.
Who are the key members and board of directors at Rv Lifesciences?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Juie Pavle  | Company Secretary | 19-Dec-2022 | Current |
| Hitesh Bhandari | CFO | 26-Jun-2017 | Current |
Board Members (10)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rajiv Sharma | Additional Director | 18-Sep-2024 | Current |
| Hanumantha Kamma | Director | 02-Feb-2021 | Current |
| Ashish Srivastava | Director | 18-Aug-2018 | Current |
| Rajesh Kumar | Director | 02-Apr-2017 | Current |
| Subrata Burman | Director | 02-Apr-2017 | Current |
| Ranjana Sharma | Director | 29-Apr-2017 | Current |
Financial Performance of Rv Lifesciences.
Rv Lifesciences Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 47.23% increase. The company also saw a substantial improvement in profitability, with a 118.45% increase in profit. The company's net worth moved up by a moderate rise of 1.58%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Rv Lifesciences?
In 2023, Rv Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Extrovis Private LimitedHanumantha Kamma is a mutual person
Octelle Impex Private LimitedRajesh Kumar is a mutual person
- Intramed Healthcare Private Limited
Subrata Burman is a mutual person
- M I Pharma Private Limited
Rajiv Sharma is a mutual person
Charges (Loans)
₹75.67 Cr
₹115.61 Cr
Charges Breakdown by Lending Institutions
- Axis Bank Limited : 75.67 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Dec 2022 | Axis Bank Limited | ₹75.67 Cr | Open |
| 19 Apr 2014 | Fullerton India Credit Company Limited | ₹3.70 Cr | Satisfied |
| 19 Oct 2013 | Vasai Vikas Sahakari Bank Ltd | ₹3.60 M | Satisfied |
| 30 Mar 2013 | Electronica Finance Limited | ₹3.90 M | Satisfied |
| 28 Feb 2013 | Electronica Finance Limited | ₹3.93 Cr | Satisfied |
How Many Employees Work at Rv Lifesciences?
Unlock and access historical data on people associated with Rv Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rv Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rv Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
